Clinical Trial Update: Molecular Tumor Board at the Center for Personalized Medicine Tübingen

View source ↗

Summary

Ongoing clinical trial at University Hospital Tuebingen investigating advanced cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Advanced Cancer | Status: RECRUITING